ColleenKellyMD

Gastroenterology • Boston, MA

Physician

Join to view full profile

Dr. Kelly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kelly's full profile

Already have an account?

Office
75 Francis St
Boston, MA 02115
Phone+1 617-732-5500

Fax+1 401-793-7801

Summary

Dr. Colleen Kelly is a gastroenterologist in Providence, RI and is affiliated with Miriam Hospital. She received her medical degree from The Ohio State University College of Medicine and has been in practice 18 years. She is experienced in general gastroenterology and inflammatory bowel disease.

Education & Training

Brown UniversityFellowship, Gastroenterology, 2003 - 2006
Boston University Medical CenterResidency, Internal Medicine, 1999 - 2002
Ohio State University College of MedicineClass of 1999

Certifications & Licensure

MA State Medical License 2001 - 2026
RI State Medical License 2005 - 2026
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013

Clinical Trials

Fecal Transplant for Relapsing C. Difficile Infection Start of enrollment: 2012 Oct 01
Unknown status
Phase 2
Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection Start of enrollment: 2015 Mar 01
Terminated
Phase 2
SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01
Completed
Phase 2
Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study Start of enrollment: 2015 May 01
Unknown status
Phase 1
Gut Microbiota Changes After Fecal Microbiota Transplantation Start of enrollment: 2015 Jun 01
Unknown status
Phase 2
Join now to see all

Publications & Presentations

PubMed

Oral Capsule FMT Combined With Bezlotoxumab Is a Successful Rescue Protocol Following Failure of FMT Alone in the Treatment of Recurrent C. difficile Infection.
Austin Hoeg, Nataliia Kuchma, Andrew Krane, Carolyn Graiziger, Juana Thomas
Journal of Clinical Gastroenterology. 2024-11-21
1 citations
Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized...
Jessica R Allegretti, Colleen R Kelly, Thomas Louie, Monika Fischer, Susy Hota
Gastroenterology. 2024-10-02
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Colleen S Kraft, Matthew Sims, Michael Silverman, Thomas J Louie, Paul Feuerstadt
Infectious Diseases and Therapy. 2024-10-01

Lectures

Probiotics, Antibiotics, and Stool Transplants (A Gut Hack – Manipulating the Microbiome)
AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/10/2018
Fecal Microbiota Transplant (FMT) in C. difficile infection
AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/9/2018

Press Mentions

‘Some May Die’: AGA Urges Continued Access to Conventional FMT for C. Difficile PatientsNovember 4th, 2024
Stay up to Date: Healio Recaps Pivotal Guidelines for GI, Liver Disease in 2024 (So Far)September 17th, 2024
AGA Guideline Endorses FMT for Recurrent C. Difficile; ‘Not yet Advised’ for IBS, IBDFebruary 21st, 2024
Join now to see all

Professional Memberships

American College of Gastroenterology - ACG
Member